Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (154)

Latest Posts

About This Stock More About This Stock
The 10 Best Dividend Kings For Long-Term Total Returns
Article By: SureDividend
Sunday, May 27, 2018 12:42 PM EDT
Dividend Aristocrats are a great source of dividend growth, but there is a smaller group of stocks with a longer history of dividend increases. The Dividend Kings are a group of just 25 stocks, each with 50+ consecutive years of dividend growth.
In this article: ITW, KO, MMM, SJW, CL, JNJ, GPC, PG, DOV, LOW Also: BRK-A, COTY
Dow 30 Stock Roundup: Walmart, Cisco, Home Depot Beat On Earnings
Article By: Swarup Gupta
Friday, May 18, 2018 7:42 PM EDT
The Dow snapped a record streak of wins to traverse a turbulent week. Trade-war related concerns continued to weigh on investors with President Trump expressing doubts over the success of upcoming negotiations with China.
In this article: BRK-B, GE, HD, JNJ, JPM, M, PFE, WMT, AAPL, AMGN, CSCO
What Can I Expect To Make If I Invest In Johnson & Johnson Today?
Video By: Chuck Carnevale
Tuesday, May 15, 2018 5:35 PM EDT
For much of 2016 and most of 2017, Johnson & Johnson was a little pricey. However, in 2018 Johnson & Johnson’s stock price has been steadily moving towards alignment with intrinsic value.
In this video: JNJ
Pharma Stock Roundup: Mixed Q1 For MRK, PFE, FDA Nod For Kymriah's 2nd Indication
Article By: Zacks Investment Research
Friday, May 4, 2018 8:15 PM EDT
First-quarter results of pharma bigwigs like Pfizer, Merck and Allergan stole the limelight this week. Other than that, Novartis gained FDA approval for the second indication of its CAR-T therapy, Kymriah.
In this article: AGN, JNJ, MRK, NVS, PFE, UTHR, ABBV
J&J Tops Q1 Earnings Estimates, Raises Sales Guidance
Article By: Zacks Investment Research
Tuesday, April 17, 2018 1:00 PM EDT
J&J’s first-quarter 2018 earnings came in at $2.06 per share.
In this article: JNJ Also: MRK, PFE, ABBV


Latest Tweets for $JNJ

No tweets yet!